CARBAFIN will establish a new value chain for utilization of surplus sugar beet biomass in the EU by converting glucose and fructose separately into value-added products. The project finds and develops new applications for glycosylated products in the food and feed-, cosmetics-, detergents- and polymer sector and for fructose as precursor of the platform chemical 5-hydroxymethylfurfural (HMF).
CARBAFIN is a collaborative research project, which started in January 2018 and will last until December 2021. It is co-financed by the European Union with a funding of 5.3 million Euros. The EU-consortium consists of eight members coming from five different countries.
Company Details
- Founded
- 2018
- Address
- Petersgasse 14, Graz,steiermark 8010,austria
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.carbafin.eu/
- HQ
- Graz, Steiermark
Carbafin Questions
Carbafin's website is http://www.carbafin.eu/
Carbafin's LinkedIn profile is https://at.linkedin.com/company/carbafin
Carbafin's industry is
Biotechnology Research
Carbafin's top competitors are
Fluvicon,
Acib Gmbh,
Econutri,
Carbomed Medical Solutions Gmbh,
Bisy,
Angelini Pharma Österreich,
Evomedis Gmbh,
Kilobaser,
Validogen Gmbh,
Meon Medical Solutions.
Carbafin's categories are Biotechnology Research
Carbafin's founding year is 2018
